Unity Biotechnology's basic earnings per share (Basic EPS) for the
three
months ended in Dec. 2023 was $-0.04.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.70.
Unity Biotechnology's EPS without NRI for the
three
months ended in Dec. 2023 was $-0.43.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -2.71.
During the past 3 years, the average EPS without NRIGrowth Rate was 46.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 34.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 8 years, Unity Biotechnology's highest 3-Year average EPS without NRI Growth Rate was 48.30% per year. The lowest was 24.60% per year. And the median was 32.10% per year.
Unity Biotechnology EPS (Basic) Historical Data
The historical data trend for Unity Biotechnology's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Unity Biotechnology's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.70
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Unity Biotechnology EPS (Basic) Related Terms
Thank you for viewing the detailed overview of Unity Biotechnology's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Unity Biotechnology (Unity Biotechnology) Business Description
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
UBX has been successfully added to your 